MRUS
Price
$94.55
Change
+$0.17 (+0.18%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
7.17B
21 days until earnings call
NUVL
Price
$88.02
Change
+$3.16 (+3.72%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
6.12B
28 days until earnings call
Interact to see
Advertisement

MRUS vs NUVL

Header iconMRUS vs NUVL Comparison
Open Charts MRUS vs NUVLBanner chart's image
Merus
Price$94.55
Change+$0.17 (+0.18%)
Volume$18.19K
Capitalization7.17B
Nuvalent
Price$88.02
Change+$3.16 (+3.72%)
Volume$4.56K
Capitalization6.12B
MRUS vs NUVL Comparison Chart in %
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRUS vs. NUVL commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRUS is a Buy and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (MRUS: $94.58 vs. NUVL: $88.00)
Brand notoriety: MRUS and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRUS: 131% vs. NUVL: 77%
Market capitalization -- MRUS: $7.17B vs. NUVL: $6.12B
MRUS [@Biotechnology] is valued at $7.17B. NUVL’s [@Biotechnology] market capitalization is $6.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRUS’s FA Score shows that 1 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • MRUS’s FA Score: 1 green, 4 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, MRUS is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRUS’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 7 bullish TA indicator(s).

  • MRUS’s TA Score: 4 bullish, 4 bearish.
  • NUVL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than MRUS.

Price Growth

MRUS (@Biotechnology) experienced а +0.46% price change this week, while NUVL (@Biotechnology) price change was +4.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.88%. For the same industry, the average monthly price growth was +22.21%, and the average quarterly price growth was +89.30%.

Reported Earning Dates

MRUS is expected to report earnings on Oct 30, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($7.17B) has a higher market cap than NUVL($6.12B). MRUS YTD gains are higher at: 124.923 vs. NUVL (8.406). MRUS (-347.56M) and NUVL (-362.01M) have comparable annual earnings (EBITDA) . NUVL has more cash in the bank: 1.01B vs. MRUS (710M). MRUS has higher revenues than NUVL: MRUS (56.2M) vs NUVL (0).
MRUSNUVLMRUS / NUVL
Capitalization7.17B6.12B117%
EBITDA-347.56M-362.01M96%
Gain YTD124.9238.4061,486%
P/E RatioN/AN/A-
Revenue56.2M0-
Total Cash710M1.01B71%
Total Debt11MN/A-
FUNDAMENTALS RATINGS
MRUS: Fundamental Ratings
MRUS
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRUSNUVL
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 24 days ago
76%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALCFX100.34N/A
N/A
Alger Focus Equity C
MCYVX13.60-0.01
-0.07%
NYLI Candriam Emerging Markets Eq Inv Cl
WGIFX75.94-0.28
-0.37%
American Funds Capital World Gr&Inc F2
JSVQX29.36-0.24
-0.81%
JPMorgan Small Cap Value R4
STSRX17.03-0.14
-0.82%
American Beacon Stephens Sm Cp Gr R6